...
首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >A polysaccharide extract of mulberry leaf ameliorates hepatic glucose metabolism and insulin signaling in rats with type 2 diabetes induced by high fat-diet and streptozotocin
【24h】

A polysaccharide extract of mulberry leaf ameliorates hepatic glucose metabolism and insulin signaling in rats with type 2 diabetes induced by high fat-diet and streptozotocin

机译:桑叶多糖提取物改善高脂饮食和链脲佐菌素诱导的2型糖尿病大鼠的肝糖代谢和胰岛素信号传导

获取原文
获取原文并翻译 | 示例
           

摘要

Mulberry leaf is a traditional medicine used to treat diabetes in the clinic. The aim of this study was to determine the mechanisms by which mulberry leaf polysaccharide (MLPII), improves hepatic glucose metabolism and insulin resistance in rats with type 2 diabetes induced by high fat and streptozotocin (STZ). MLPII was administered for 6 weeks after establishment of type 2 diabetes in Wistar rats. At the end of the experiment, oral glucose tolerance, liver glycogen content, glucose synthase (GS) activity and insulin resistance were determined. Expression patterns of proteins and genes associated with insulin signaling as well as biomarkers of oxidative stress and antioxidant enzyme activities were assayed. Compared with normal control rats, MLPII treatment significantly improved oral glucose tolerance (P<0.01) and restored the glycogen level (P<0.01) and GS activity (P<0.05) in diabetic rats. Insulin resistance was improved in MLPII-treated diabetic rats (P<0.01). Furthermore, expression levels of insulin receptor ;substrate 2 (IRS2), phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB/AKT) involved in insulin signaling were significantly increased (P<0.01), while protein-tyrosine phosphatase 1B (PTP1B) expression was markedly reduced (P<0.01). The levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) in livers of the MLPII-treated group were significantly reduced (P<0.01), while activities of the antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx), were significantly increased (P<0.01, P<0.01, P<0.01, respectively). The results clearly indicate that MLPII treatment effectively normalizes hepatic glucose metabolism and insulin signaling by inhibiting the expression of PTP1B, activating the PI3K-AKT pathway and mitigating oxidative stress in the livers of rats with type 2 diabetes induced by high fat and STZ. (C) 2014 Elsevier B.V. All rights reserved.
机译:桑叶是临床上用于治疗糖尿病的传统药物。这项研究的目的是确定桑叶多糖(MLPII)改善高脂和链脲佐菌素(STZ)诱导的2型糖尿病大鼠肝糖代谢和胰岛素抵抗的机制。在Wistar大鼠中建立2型糖尿病后,给予MLPII 6周。在实验结束时,确定了口服葡萄糖耐量,肝糖原含量,葡萄糖合酶(GS)活性和胰岛素抵抗。分析了与胰岛素信号传导相关的蛋白质和基因的表达模式,以及氧化应激和抗氧化酶活性的生物标记。与正常对照组相比,MLPII治疗显着改善了糖尿病大鼠的口服葡萄糖耐量(P <0.01),并恢复了糖原水平(P <0.01)和GS活性(P <0.05)。接受MLPII治疗的糖尿病大鼠的胰岛素抵抗得到改善(P <0.01)。此外,参与胰岛素信号传导的胰岛素受体,底物2(IRS2),磷脂酰肌醇3激酶(PI3K)和蛋白激酶B(PKB / AKT)的表达水平显着增加(P <0.01),而蛋白酪氨酸磷酸酶1B( PTP1B)表达显着降低(P <0.01)。 MLPII治疗组的肝脏中8-羟基-2-脱氧鸟苷(8-OHdG)和丙二醛(MDA)的水平显着降低(P <0.01),而抗氧化酶,超氧化物歧化酶(SOD),过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GPx)显着增加(分别为P <0.01,P <0.01,P <0.01)。结果清楚地表明,MLPII治疗通过抑制PTP1B的表达,激活PI3K-AKT途径并减轻高脂和STZ诱导的2型糖尿病大鼠肝脏中的氧化应激,从而有效地使肝脏葡萄糖代谢和胰岛素信号转导正常化。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号